Katarina Dakay, Jared Cooper, Jessica Bloomfield, Philip Overby, Stephan A Mayer, Rolla Nuoman, Ramandeep Sahni, Edwin Gulko, Gurmeen Kaur, Justin Santarelli, Chirag D Gandhi, Fawaz Al-Mufti
SARS-CoV-2, the virus responsible for novel Coronavirus (COVID-19) infection, has recently been associated with a myriad of hematologic derangements; in particular, an unusually high incidence of venous thromboembolism has been reported in patients with COVID-19 infection. It is postulated that either the cytokine storm induced by the viral infection or endothelial damage caused by viral binding to the ACE-2 receptor may activate a cascade leading to a hypercoaguable state. Although pulmonary embolism and deep venous thrombosis have been well described in patients with COVID-19 infection, there is a paucity of literature on cerebral venous sinus thrombosis (cVST) associated with COVID-19 infection...
January 2021: Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association